chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Heart attack occured October 27, 2021 at approximately 10:30 am. Surgeon at hospital put stent in my right coronary artery
heard of 4 or 5 people with heart attacks after the COVID-19 Vaccine; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MYOCARDIAL INFARCTION (medically significant), outcome "unknown", described as "heard of 4 or 5 people with heart attacks after the COVID-19 Vaccine".  Clinical course:Reporter wanted to know if this had been reported since he didn't find any information on the internet. Then mentioned about how he heard of 4 or 5 people with heart attacks after the COVID-19 Vaccine. He added that he's obviously not going to take another booster. When reporter was referred to his HCP, he mentioned that in one of the visits, he was told the booster reacts with immunological system and that his doctor said things that didn't made sense, and that he was actually medical misdiagnosed, which was common to happen to him. Knows people who have heart attacks from the shot. Has heard several people with recent immunization, who got the shot, had heart attacks. Reporter did not have anything like that. Knows people who have heart attacks from the shot. Has heard several people with recent immunization, who got the shot, had heart attacks. Reporter did not have anything like that.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report was received from a medical assistant refers to a patient of unknown age and gender. In September 2012, the patient was vaccinated with the first dose of RECOMBIVAX HB (dose, route and lot not reported) and on 20-DEC-2012 the patient received the second dose of RECOMBIVAX HB late. The patient was not experiencing any known symptoms. The outcome of the event was unknown. The reporter considered the event to be not related to RECOMBIVAX HB. Additional information has been requested.
Headache, NauseaVomiting, FATIGUE Narrative: TWO DAYS WITH FATIGUE/HEADACHE/NAUSEA
chills in middle of the night; pain where the injection is; feel kind of weak; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team. The reporter is the patient.  An 83-year-old male patient received BNT162b2 (BNT162B2), on 13Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "COVID-19", start date: 2020 (unspecified if ongoing), notes: Had Covid 2 years ago; "he almost died from it.", start date: 2020 (unspecified if ongoing); "ventilator for 17 days", start date: 2020 (unspecified if ongoing), notes: He had Covid 2 years ago and was on a ventilator for 17 days.; "He lost 35 pounds", start date: 2020 (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, single), for COVID-19 immunization; Covid-19 vaccine (Dose 2, single), for COVID-19 immunization; Covid-19 vaccine (Dose 3(Booster dose), single), for COVID-19 immunization. The following information was reported: CHILLS (non-serious) with onset Apr2022, outcome "unknown", described as "chills in middle of the night"; ASTHENIA (non-serious) with onset Apr2022, outcome "unknown", described as "feel kind of weak"; VACCINATION SITE PAIN (non-serious) with onset Apr2022, outcome "unknown", described as "pain where the injection is". Additional information Reporter states he had the second Pfizer Booster shot yesterday. Clarified that he is referring to the Pfizer Covid-19 vaccine, second booster shot. Dentist who received the booster dose of Pfizer-BioNTech COVID-19 Vaccine yesterday (13Apr2022). He states, he had chills in the middle of the night. He has pain where the injection is and feels kind of weak. He had Covid 2 years ago and was on a ventilator for 17 days. He lost 35 pounds and almost died but he is alive now. His daughter had a 5-week baby and they are going to visit him. Is there any possible potential infection from getting the second Pfizer Booster, for the new baby. Clarified that his question is regarding him getting the second booster and how it will affect the baby. He asks it is ok from him to be near the baby, given the problems he has had. He can live with the pain and discomfort. He states he has a pretty tight schedule and does not like people calling out of the blue   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Patient was inadvertently given booster (dose #3) of Moderna too early.  Dose #2 was given 10/19/21 and dose #3 was given 2/19/22, which is early than the recommended 5-month interval.
No adverse event at this time. The patient received a booster dose of Pfizer when he received Moderna for his two initial vaccines.
no adverse event; got the pediatric dose, 0.5 ml, at age 19; This spontaneous report was received from a nurse referring to a 19 years old patient of unknown gender. There was no information about the patient's concurrent conditions, drug reactions, allergies, medical history, and concomitant therapies provided.  On an unknown date (reported at age 18), the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) 0.5 ml (route, lot number and expiration date were not reported) for prophylaxis. On 17-DEC-2020, the patient was vaccinated with the pediatric dose of hepatitis a vaccine, inactivated (VAQTA) (0.5 ml, lot # T022333 with expiration date 11-DEC-2021; route was not reported) for prophylaxis at age 19 (incorrect dosage administered). No other AE reported.
Sense of taste is still off. I can barely taste my food until it hits my throat but not my taste buds; This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient.  A 39-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 14Dec2022 as dose 1, single (Lot number: FP7138) at the age of 39 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Fibromyalgia" (unspecified if ongoing); "Scoliosis" (unspecified if ongoing); "Herniated disk c4-c5" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: AGEUSIA (non-serious) with onset 16Dec2022, outcome "not recovered", described as "Sense of taste is still off. I can barely taste my food until it hits my throat but not my taste buds". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of ageusia.  Additional information: Patient also received BNT162b2 (BNT162B2), on 06Jan2023 as dose 2, single (Lot number: FP7138) in right arm for covid-19 immunisation. Patient had no known allergies. No other vaccine in four weeks was administered. Other medications in two weeks: Not applicable. COVID prior vaccination: No
102 Fever; Chills; Fatigue; Swollen glands under left armpit; Dose received 3 / dose number=3 of BNT162b2; This is a spontaneous report received from a contactable reporter (consumer). The reporter is the patient.  A 50-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), administered in left arm, administration date 26Nov2021 at 16:00 (Batch/Lot number: ) at the age of 50 years as dose 3 (booster), single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; DOSE 2, SINGLE; Lot Number: 3248; Anatomical Location: Left arm; Route of Administration: Unspecified), administration date: 23Mar2021, single for COVID-19 immunisation and BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; DOSE 1, SINGLE; Lot Number: 3248; Anatomical Location: Left arm; Route of Administration: Unspecified), administration date: 02Mar2021, single for COVID-19 immunisation.  The following information was reported: PYREXIA (non-serious), CHILLS (non-serious), FATIGUE (non-serious), LYMPHADENOPATHY (non-serious), all with onset 27Nov2021, outcome "recovering", described as "102 fever, chills, fatigue, swollen glands under left armpit ". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pyrexia, chills, fatigue and lymphadenopathy.  Additional Information: The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care.
3x5 cm area of erythema at injection site to (L) deltoid, slightly tender and warmth to touch.
Breakthrough Case:  Patient was fully vaccinated, first dose on 1/8/21 and second dose on 2/4/21.  Tested positive for COVID-19 on 11/20/21.
Sudden shooting partial numbness and tingling from injection site into hands and fingers. This led to complete numbness of ring and pinky finger.  Following these events, menstrual period was irregular, extremely heavy, and painful for 4+ weeks. Despite taking birth control, I experienced extremely high levels of bleeding , had period-like flow while taking active pills, and no bleeding during one week of water pills. Most painful and irregular period I have had since 12 years old.
This spontaneous report as received from a registered pharmacist refers to a 20 year old female patient. The pharmacist reported that the patient received first dose of GARDASIL (dose, route and lot # not provided) at 14 years of age (approximately in 2007) and was in pharmacy to receive the second dose of GARDASIL on 30-JUL-2013. No adverse effect. It was unknown if the patient had sought medical attention. Additional information has been requested.
This case was reported by a consumer via call center representative and described the occurrence of lip swelling in a adult female patient who received SHINGRIX for prophylaxis. On 31st March 2019, the patient received SHINGRIX. On an unknown date, 1 day after receiving SHINGRIX, the patient experienced lip swelling. On an unknown date, the outcome of the lip swelling was not recovered/not resolved. It was unknown if the reporter considered the lip swelling to be related to SHINGRIX. Additional details were provided as follows: The patient reported that she received the SHINGRIX vaccine the day before reporting day and she awoke in the morning of reporting day with swollen lips. The reporter did not consent to follow up. The patient refused to provide any details or demographic and name information.
Swelling in underarm on left side wher shot administered. Lasted less than 24 hours. Congestion and tenderserness day 3-4, just over
Became shaky (helped her sit down), slight slurring of speech, sweating, rapid heart rate. Called her physician who stated to call 911 (as per my recommendation).
Patient reported breaking out with hives, scattered on trunk and arms, continuing 5 days post vaccination.  No difficulty breathing or any other symptoms reported.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a female patient who received SHINGRIX for prophylaxis. On 1st August 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, immediately after receiving SHINGRIX, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown. It was unknown if the reporter considered the injection site pain to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The patient reported that the SHINGRIX vaccine was very painful. The patient always gets the flu vaccine and it only hurts a little. SHINGRIX hurt a lot more. The reporter did not consent to follow up. This case has been linked with US2019GSK010444, reported by same reporter.
Patient fainted during the 15 minute waiting period after vaccination of primary dose of Janssen. Patient stood up from the waiting chair and got dizzy and lost his balance and spun around and fell into the 4 way display. The back of his neck scraped one of the shelves as he fell and the skin was scraped with faint amount of blood appearing. Patient fell to the ground but did not hit his head. Patient's mother was with him and helped him get off the floor. When I arrived to the patient I checked for any injury and verified that he was ok to sit down, then I got him a cold ice pack to apply to his face and neck. Patient had syncope with paleness, sweating, nausea, dizziness, brief loss of consciousness with visual disturbance. I advised patient to lie down on their back and elevate their feet. Patient rested in the waiting area for another 15 minutes and I continued to check on him until he felt better to leave. His parents helped him walk out of the store and said they would drive him home and not let him drive himself.
A consumer report has been received. The report concerns a Male patient who received FLUMIST (INTRANASAL), 0.2 Millilitres, Unknown. FLUMIST (INTRANASAL) was started on an unknown date. The patient experienced TRYPANOPHOBIC. The outcome of the event of TRYPANOPHOBIC was unknown. The report was considered to be non-serious.
Pt's mother reports post vaccine that evening injection site red 3" diameter, by morning the swelling encompassed the entire front of left leg.
I'm not feeling well; This is a spontaneous report from a Pfizer-Sponsored program Pfizer.  Together received from a contactable consumer (patient). A 65-years-old female patient received BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine via an unspecified route of administration on an unspecified date, at 65 years of age, (Batch/Lot number was not reported) as single dose for COVID-19 immunization and palbociclib (IBRANCE), via an unspecified route of administration from an unspecified date (Batch/Lot number was not reported), at 125 mg for Malignant neoplasm of unspecified site of left female breast. Medical history included breast cancer and chronic obstructive pulmonary disease, both from an unknown date. The patient's concomitant medications were not reported. On an unspecified date, the day after vaccination, the patient was not feeling well. The action taken with palbociclib in response to the event was unknown. At the time of the report the event outcome was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
90 minutes after receipt of flu vaccine, pt complained of SOB and felt cold. Pt with prior diagnosis of COPD. Refused medical treatment. Took breathing Rx as prescribed for chronic condition. Next day had fever 100.2 F and persistent complaints of SOB. Refused to seek medical treatment. Expired later in day approximately 29 hours after immunization.
Dizzy and warm feeling lasting for 30 minutes, 31 weeks pregnant After 30minutes patient wanted something to drink, gave a water  Husband came at 45 minutes, gave an orange and took her home, she was feeling better
IMMUNITY ALSO HIGH BUT NOT AS HIGH AS WIFE; FEET WERE KILLING HIM; This spontaneous report received from a consumer concerned a 70 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A expiry: UNKNOWN) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 07-APR-2021, the patient experienced feet were killing him. On an unspecified date, the patient experienced immunity also high but not as high as wife. Laboratory data (dates unspecified) included: SARS-CoV-2 antibody test (NR: not provided) High. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from feet were killing him on 07-APR-2021, and the outcome of immunity also high but not as high as wife was not reported. This report was non-serious. This case, from the same reporter is linked to 20210852005.
This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (COVID-19) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Rheumatoid arthritis (Mild well controlled) and Allergy NOS. On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Mar-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-May-2022, the patient experienced COVID-19 (COVID-19). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 18-May-2022 to 22-May-2022 for COVID-19 treatment, at an unspecified dose and frequency. At the time of the report, COVID-19 (COVID-19) had not resolved. Not Provided. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) Negative. Patient took unknown (active substances: Hydroxychloroquine, Methotrexate) drug as concomitant medication. The patient was taking other medications/products within 2 weeks of starting COVID-19 treatment. Patient previously received a COVID-19 Vaccine. Patient had Covid reinfection after testing negative for days after Paxlovid. Device Date: 30May2022. Company Comment: This is a spontaneous case concerning a 67-year-old female patient with no relevant medical history, who experienced the unexpected, non-serious, adverse event of special interest, COVID-19 (reported as Covid reinfection after testing negative for days after) which occurred approximately 2 months after receiving the fourth dose of mRNA-1273 Vaccine. As reported, the patient was treated with Paxlovid for COVID-19 for 5 days and had COVID reinfection after testing negative for days after Paxlovid. The event of COVID-19 is in relationship with the treatment drug Paxlovid based on start of treatment date and onset date of event. No other clinical or treatment details were given. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report. Sender's Comments: This is a spontaneous case concerning a 67-year-old female patient with no relevant medical history, who experienced the unexpected, non-serious, adverse event of special interest, COVID-19 (reported as Covid reinfection after testing negative for days after) which occurred approximately 2 months after receiving the fourth dose of mRNA-1273 Vaccine. As reported, the patient was treated with Paxlovid for COVID-19 for 5 days and had COVID reinfection after testing negative for days after Paxlovid. The event of COVID-19 is in relationship with the treatment drug Paxlovid based on start of treatment date and onset date of event. No other clinical or treatment details were given. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.
Dizziness, Lightheaded (mild) BP 150/86, HR78 -- > 128/54, 74; Patient stable and released from vaccination site
Information has been received from a nurse referring to a patient of unknown age and gender. The patient's concurrent conditions, concomitant medication and medical history were not provided. On 01-OCT-2015 the patient was vaccinated with an improperly stored dose of ROTATEQ (lot # K009745, expiry date 17-FEB-2016, dose and dose number were unspecified) orally. No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 10-JAN-2017, the patient was vaccinated with an expired dose of ZOSTAVAX, with lot # L038926 and expiration date 06-JAN-2017 (dose and route of administration were not provided), for prophylaxis. No adverse events were reported. There was no a product quality complaint (PQC) involved. Additional information has been requested.
Woke up with ringing in my ears. It was intense ringing. It has gone down over the last several weeks. But it still quite noticeable. I never had a tinnitus before and it is most noticeable at night so it interferes with my sleep. I am scheduled to see an audiologist/ENT, but not until November 3, 2021.
pt. recvd 1st hepatitis B vac & exp. tiredness, weakness in legs & nausea.
Information has been received from a medical assistant concerning a 20-21 year old female who on 07-SEP-2007 was vaccinated intramuscularly with a second dose of GARDASIL. On 07-SEP-SEP within 12 minutes of leaving the office the patient reported "blacking out at the wheel" and was involved in a motor vehicle accident. The patient did not require hospitalization for the motor vehicle accident. The patient reporter feeling well when she left the office. There was no laboratory or diagnostic tests performed. The patient's father came to the physician's office 1 - 1 1/2 hours later to inform the physician. At the time of the report the patient's outcome unknown. Additional information has been requested.
Started with fevers around June 1, had fever off & on. On 6/28 was seen with severe neurological symptoms and admitted with positive encephalitis. Father convinced this was from vaccine.
For 24 hours Shivering Chills Trouble breathing Fever Headache Weakness Fatigue After 24 hours Weakness and fatigue
Patient called on 10/27/16 and reported shoulder and arm pain. Pain increased throughout the day and had mobility issues at end of the day. Also painful at night while sleeping. Patients reported tenderness to touch after flu shot and other symptoms occurred later. Patient has no see her physician yet.
Approximately one week and a half following my second vaccine, I abruptly developed paresthesia in my hands and feet. This is persistent and feels like constant numbness. I also had a prolonged headache and fatigue. Also, the arm is which is received the injection has chronic pain all the way down. My parenthesis goes up to my elbows, and approximately up to the mid part of my legs. This has not yet resolved. I have seen my primary care doctor and am being referred to a neurologist.
large erythematous area 7" x 3.5", hot to touch demarcated borders middle of area is hard not painful
Given vaccine in left arm. Arm was swollen around vaccine site the next day. Followed up in our office 2 days later.
Patient had area redness 2 1/2 by 3 inches with 1 1/2 by 1 3/4 induration.
Patient reports "3 days later my arm was itching, swollen, red, my arm was splotchy"
Generalized weakness for one week. Admitted to the hospital with a DX of Gullian Barre.